Experimental Alzheimer’s drug slows cognitive decline, focus shifts to side effects

This recent Reuters piece highlights a new experimental Alzheimer’s drug from Eisai & Biogen which has shown evidence of effectively slowing cognitive decline. Researchers are taking a closer look at reported side effects.

Related Articles

Responses